Barinthus Biotherapeutics merger closes, shareholders receive 0.111 Topco shares per share
Reuters2026/09/09 14:26- Topco completed its acquisition of Barinthus Biotherapeutics, taking all issued and to-be-issued ordinary shares at the scheme effective time.
- Each Barinthus share, including those underlying ADSs, was exchanged for 0.111 shares of Topco common stock.
- Fractional share entitlements will be cashed out under the scheme and merger agreement terms.
- The ADS deposit agreement dated April 29, 2021, with Bank of New York Mellon was terminated upon effectiveness.
- Outstanding equity options were converted into Topco options on substantially the same vesting and exercise terms.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
"Smart money" makes massive purchases of U.S. stocks! Bank of America clients record the sixth highest weekly net purchases in history, technology stocks favored again
According to the latest client fund flow data from Bank of America, last week its clients recorded a net purchase of U.S. stocks for the second consecutive week, with the inflow reaching the highest level since mid-July. This marks the sixth largest single-week net inflow since the bank began tracking weekly data in 2008.
UBS lifts Azelis stake above 3% voting rights threshold again, filing shows
Crypto prices
More
